BACKGROUND: Although telephone care management improves depression outcomes, its implementation as a standalone strategy is often not feasible in resource-constrained settings. Moreover, little research has examined the potential role of self-management support from patients' trusted confidants. OBJECTIVE: To investigate the potential benefits of integrating a patient-selected support person into automated mobile health (mHealth) for depression. DESIGN: Patient preference trial. PARTICIPANTS: Depressed primary care patients who were at risk for antidepressant nonadherence (i.e., Morisky Medication Adherence Scale total score > 1). INTERVENTION: Patients received weekly interactive voice response (IVR) telephone calls for depression that included self-management guidance. They could opt to designate a lay support person from outside their home to receive guidance on supporting their self-management. Patients' clinicians were automatically notified of urgent patient issues. MAIN MEASURES: Each week over a period of 6 months, we used IVR calls to monitor depression with the Patient Health Questionnaire-9 (PHQ-9; with total < 5 classified as remission), adherence (single item reflecting perfect adherence over the past week), and functional impairment (any bed days due to mental health). KEY RESULTS: Of 221 at-risk patients, 61% participated with a support person. Analyses were adjusted for race, medical comorbidity, and baseline levels of symptom severity and adherence. Significant interaction effects indicated that during the initial phase of the program, only patients who participated with a support person improved significantly in their likelihood of either adhering to antidepressant medication (AOR = 1.31, 95% CI: 1.16-1.47, p < 0.001) or achieving remission of depression symptoms (AOR = 1.24, 95% CI: 1.14-1.34, p < 0.001). These benefits were maintained throughout the 6-month observation period. CONCLUSIONS: Incorporating the "human factor" of a patient-selected support person into automated mHealth for depression self-management may yield sustained improvements in antidepressant adherence and depression symptom remission. However, this needs to be confirmed in a subsequent randomized controlled trial.
BACKGROUND: Although telephone care management improves depression outcomes, its implementation as a standalone strategy is often not feasible in resource-constrained settings. Moreover, little research has examined the potential role of self-management support from patients' trusted confidants. OBJECTIVE: To investigate the potential benefits of integrating a patient-selected support person into automated mobile health (mHealth) for depression. DESIGN:Patient preference trial. PARTICIPANTS: Depressed primary care patients who were at risk for antidepressant nonadherence (i.e., Morisky Medication Adherence Scale total score > 1). INTERVENTION: Patients received weekly interactive voice response (IVR) telephone calls for depression that included self-management guidance. They could opt to designate a lay support person from outside their home to receive guidance on supporting their self-management. Patients' clinicians were automatically notified of urgent patient issues. MAIN MEASURES: Each week over a period of 6 months, we used IVR calls to monitor depression with the Patient Health Questionnaire-9 (PHQ-9; with total < 5 classified as remission), adherence (single item reflecting perfect adherence over the past week), and functional impairment (any bed days due to mental health). KEY RESULTS: Of 221 at-risk patients, 61% participated with a support person. Analyses were adjusted for race, medical comorbidity, and baseline levels of symptom severity and adherence. Significant interaction effects indicated that during the initial phase of the program, only patients who participated with a support person improved significantly in their likelihood of either adhering to antidepressant medication (AOR = 1.31, 95% CI: 1.16-1.47, p < 0.001) or achieving remission of depression symptoms (AOR = 1.24, 95% CI: 1.14-1.34, p < 0.001). These benefits were maintained throughout the 6-month observation period. CONCLUSIONS: Incorporating the "human factor" of a patient-selected support person into automated mHealth for depression self-management may yield sustained improvements in antidepressant adherence and depression symptom remission. However, this needs to be confirmed in a subsequent randomized controlled trial.
Authors: Michael J Stirratt; Jacqueline Dunbar-Jacob; Heidi M Crane; Jane M Simoni; Susan Czajkowski; Marisa E Hilliard; James E Aikens; Christine M Hunter; Dawn I Velligan; Kristen Huntley; Gbenga Ogedegbe; Cynthia S Rand; Eleanor Schron; Wendy J Nilsen Journal: Transl Behav Med Date: 2015-07-09 Impact factor: 3.046
Authors: Heidi K Moore; James C Mundt; Jack G Modell; Heidi E Rodrigues; David J DeBrota; James J Jefferson; John H Greist Journal: J Clin Psychopharmacol Date: 2006-06 Impact factor: 3.153
Authors: Tara W Strine; Kurt Kroenke; Satvinder Dhingra; Lina S Balluz; Olinda Gonzalez; Joyce T Berry; Ali H Mokdad Journal: J Nerv Ment Dis Date: 2009-01 Impact factor: 2.254
Authors: Sona Dimidjian; Steven D Hollon; Keith S Dobson; Karen B Schmaling; Robert J Kohlenberg; Michael E Addis; Robert Gallop; Joseph B McGlinchey; David K Markley; Jackie K Gollan; David C Atkins; David L Dunner; Neil S Jacobson Journal: J Consult Clin Psychol Date: 2006-08
Authors: James E Aikens; Donald E Nease; David P Nau; Michael S Klinkman; Thomas L Schwenk Journal: Ann Fam Med Date: 2005 Jan-Feb Impact factor: 5.166
Authors: Kurt Kroenke; Tara W Strine; Robert L Spitzer; Janet B W Williams; Joyce T Berry; Ali H Mokdad Journal: J Affect Disord Date: 2008-08-27 Impact factor: 4.839
Authors: Wagahta Semere; Scott Crossley; Andrew J Karter; Courtney R Lyles; William Brown; Mary Reed; Danielle S McNamara; Jennifer Y Liu; Dean Schillinger Journal: J Gen Intern Med Date: 2019-08-19 Impact factor: 5.128
Authors: John D Piette; Nicolle Marinec; Kathryn Janda; Emily Morgan; Karolina Schantz; Amparo Clara Aruquipa Yujra; Bismarck Pinto; José Marecelo Huayta Soto; Mary Janevic; James E Aikens Journal: Telemed J E Health Date: 2015-09-09 Impact factor: 3.536
Authors: Judith B Vick; Halima Amjad; Katherine C Smith; Cynthia M Boyd; Laura N Gitlin; David L Roth; Debra L Roter; Jennifer L Wolff Journal: Int J Geriatr Psychiatry Date: 2017-06-06 Impact factor: 3.485
Authors: John D Piette; Dana Striplin; Lawrence Fisher; James E Aikens; Aaron Lee; Nicolle Marinec; Madhura Mansabdar; Jenny Chen; Lynn A Gregory; Christopher S Kim Journal: Jt Comm J Qual Patient Saf Date: 2019-12-04
Authors: Paul N Pfeiffer; Marcia Valenstein; Dara Ganoczy; Jennifer Henry; Steven K Dobscha; John D Piette Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2016-10-25 Impact factor: 4.328
Authors: Jennifer L Wolff; Jonathan D Darer; Andrea Berger; Deserae Clarke; Jamie A Green; Rebecca A Stametz; Tom Delbanco; Jan Walker Journal: J Am Med Inform Assoc Date: 2017-04-01 Impact factor: 4.497
Authors: James E Aikens; Marcia Valenstein; Melissa A Plegue; Ananda Sen; Nicolle Marinec; Eric Achtyes; John D Piette Journal: Telemed J E Health Date: 2021-06-04 Impact factor: 3.536
Authors: Denise Chang; Andrew D Carlo; Sara Khor; Lauren Drake; E Sally Lee; Marc Avery; Jürgen Unützer; David R Flum Journal: J Gen Intern Med Date: 2020-08-31 Impact factor: 5.128